Literature DB >> 1362415

Characterization of the clinical features of five families with hereditary primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2.

M F Robinson1, E J Furst, V Nunziata, M L Brandi, J P Ferrer, M J Martins Bugalho, G di Giovanni, R J Smith, D T Donovan, B R Alford.   

Abstract

The hereditary conditions of primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2 (MEN 2) are rare clinical entities. The initial reports of two families in which the two conditions coincided have led to the identification of at least eight additional families with this clinical syndrome. In this report we describe the clinical features in five of these eight families. The salient feature in these five families is the presence of unilateral (46%) or bilateral (64%) pruritic and lichenoid skin lesions located over the upper portion of the back. Family members describe these skin lesions as intermittently intensely pruritic leading to scratching and excoriation of the upper back region. The presence of MEN 2 has been documented in 97% of family members with this skin lesion, the one exception being a child who is at risk for development of MEN 2A in whom the diagnosis has not yet been made. Of family members who have MEN 2A, 27% do not have an identifiable skin lesion, although the skin lesion developed in one patient two years after a curative thyroidectomy for medullary thyroid carcinoma (MTC). Four of the five families have members with pheochromocytoma; one with five affected members has only MTC. The finding of this clinical syndrome in geographically diverse portions of the world and the lack of overlap with MEN 2A without the skin lesion suggest it is a distinct clinical variant of MEN 2A.

Entities:  

Mesh:

Year:  1992        PMID: 1362415

Source DB:  PubMed          Journal:  Henry Ford Hosp Med J        ISSN: 0018-0416


  8 in total

1.  Seventeen-year-long follow-up of a family affected by type 2A multiple endocrine neoplasia (MEN 2A).

Authors:  A Libroia; U Verga; G Vecchi; F Banfi; F Zurleni; L Quadro; C Scurini; O Fattoruso; V Colantuoni
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

Review 2.  MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.

Authors:  Jessica Oliboni Scapineli; Lucieli Ceolin; Márcia Khaled Puñales; José Miguel Dora; Ana Luiza Maia
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

3.  Multiple endocrine neoplasia type 2A/localized cutaneous lichen amyloidosis associated with malignant pheochromocytoma and ganglioneuroma.

Authors:  S Gullu; A Gursoy; M F Erdogan; S Dizbaysak; G Erdogan; N Kamel
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

Review 4.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

5.  Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends.

Authors:  George N Zografos; George K Vasiliadis; Flora Zagouri; Chrysanthi Aggeli; Dimitris Korkolis; Sophia Vogiaki; Matina K Pagoni; Gregory Kaltsas; George Piaditis
Journal:  World J Surg Oncol       Date:  2010-03-10       Impact factor: 2.754

6.  Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis.

Authors:  I Ceccherini; C Romei; V Barone; F Pacini; E Martino; A Loviselli; A Pinchera; G Romeo
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

Review 7.  Multiple endocrine neoplasia type 2.

Authors:  Francesca Marini; Alberto Falchetti; Francesca Del Monte; Silvia Carbonell Sala; Isabella Tognarini; Ettore Luzi; Maria Luisa Brandi
Journal:  Orphanet J Rare Dis       Date:  2006-11-14       Impact factor: 4.123

Review 8.  Paragangliomas/Pheochromocytomas: clinically oriented genetic testing.

Authors:  Rute Martins; Maria João Bugalho
Journal:  Int J Endocrinol       Date:  2014-05-12       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.